rekambys
janssen-cilag international nv - rilpivirine - infezioni da hiv - antivirali per uso sistemico - rekambys is indicated, in combination with cabotegravir injection, for the treatment of human immunodeficiency virus type 1 (hiv 1) infection in adults who are virologically suppressed (hiv-1 rna < 50 copies/ml) on a stable antiretroviral regimen without present or past evidence of viral resistance to, and no prior virological failure with, agents of the nnrti and ini class.
freka-clyss clistere
fresenius kabi (schweiz) ag - natrii dihydrogenophosphas anhydricus, dinatrii phosphas - clistere - natrii dihydrogenophosphas anhydricus 139.1 mg, dinatrii phosphas 31.8 mg, e 211 1 mg, e 218 0.5 mg, natrii hydroxidum ad ph, aqua purificata ad solutionem pro 1 ml, pro vase 133 ml. - laxans - synthetika
rekambys 600 mg / 2 ml deposito-injektionssuspension
janssen-cilag ag - rilpivirinum - deposito-injektionssuspension - rilpivirinum 600 mg, poloxamerum 338, glucosum monohydricum, natrii dihydrogenophosphas monohydricus, acidum citricum monohydricum, natrii hydroxidum, aqua ad iniectabile q.s. ad suspensionem pro 2 ml corresp. natrium 1.66 mg. - l'infezione da hiv - synthetika
rekambys 900 mg / 3 ml deposito-injektionssuspension
janssen-cilag ag - rilpivirinum - deposito-injektionssuspension - rilpivirinum 900 mg, poloxamerum 338, glucosum monohydricum, natrii dihydrogenophosphas monohydricus, acidum citricum monohydricum, natrii hydroxidum, aqua ad iniectabile q.s. ad suspensionem pro 3 ml corresp. natrium 2.49 mg. - l'infezione da hiv - synthetika
frekaderm colourless
fresenius medical care ag & co kgaa - disinfettanti e antisettici - altri
frekasept 80
fresenius medical care ag & co kgaa - disinfettanti e antisettici - altri
frekaflexᆴ nacl 0,9% 250 ml
fresenius medical care ag & co kgaa - dispositivi per dialisi - altri
frekaflexᆴ nacl 0,9% 1000 ml
fresenius medical care ag & co kgaa - dispositivi per dialisi - altri
frekaflexᆴ nacl 0,9% 1000 ml
fresenius medical care ag & co kgaa - dispositivi per dialisi - altri